ArticleScientific reports2017

Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.

Ming Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.